title: Myasthenia gravis exacerbation associated with pembrolizumab.
authors.affiliation: Neuromuscular Center, Desk S90 Department of Neurology, Cleveland Clinic, Cleveland, Ohio, USA, 44195.
authors.forename: Julia
authors.initials: J
authors.lastname: Zhu
authors.affiliation: Neuromuscular Center, Desk S90 Department of Neurology, Cleveland Clinic, Cleveland, Ohio, USA, 44195.
authors.forename: Yuebing
authors.initials: Y
authors.lastname: Li
mesh_terms: D000906:Antibodies / Q000097:blood; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D000074322:Antineoplastic Agents, Immunological / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D011950:Receptors, Cholinergic / Q000276:immunology
chemical_list: D000906:Antibodies; D061067:Antibodies, Monoclonal, Humanized; D000074322:Antineoplastic Agents, Immunological; D011950:Receptors, Cholinergic; C582435:pembrolizumab